Physical stability of nonviral plasmid-based therapeutics.
about
Naked plasmid DNA formulation: effect of different disaccharides on stability after lyophilisationStabilization of pharmaceuticals to oxidative degradation.2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy.Stabilization of proteins in solid form.Drying of a plasmid containing formulation: chitosan as a protecting agent.Induction of osteogenic differentiation of stem cells via a lyophilized microRNA reverse transfection formulation on a tissue culture plateNovel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.Lyophilization of a triply unsaturated phospholipid: effects of trace metal contaminantsWomen and heart disease--physiologic regulation of gene delivery and expression: bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease.Recent developments and perspectives on gene therapy using synthetic vectors.Polymeric gene delivery for diabetic treatment.Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification.Synergistic effects of surfactants and sugars on lipoplex stability during freeze-drying and rehydration.Drying of a plasmid containing formulation: chitosan as a protecting agentEffects of moisture content on the storage stability of dried lipoplex formulations.Atmospheric freeze drying for the reduction of powder electrostatics of amorphous, low density, high surface area pharmaceutical powders.The effect of spermine on plasmid condensation and dye release observed by fluorescence correlation spectroscopy.The effect of protective agents on the stability of plasmid DNA by the process of spray-drying.Fabrication of poly(lactide-co-glycolide) scaffold filled with fibrin gel, mesenchymal stem cells, and poly(ethylene oxide)-b-poly(L-lysine)/TGF-β1 plasmid DNA complexes for cartilage restoration in vivo.Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose.Dehydrated form of plasmid expressing basic fibroblast growth factor-polyethylenimine complex is a novel and accurate method for gene transfer to the cornea.
P2860
Q33773141-BE4F09D4-311E-49C2-8958-7DE899C677ABQ34536804-4348BE23-2DEA-4A2F-ABDA-D256D67B4B14Q34747045-E65B6E46-9471-49C6-835E-4054995A7DACQ36217972-2877A837-8E7E-463F-A09B-C90844C05778Q36564757-69882307-D410-40FC-A710-D162CCCA14EAQ36825283-C678A253-0479-417A-A92A-29D84E38C568Q37228936-F500D918-89CE-4AE3-B17E-3C9348E57C49Q37231006-D9A02A4C-F0F8-40D0-8FAF-FF2444EE83B4Q37284978-3E19C7EB-A5CC-4F5E-BA84-34CA290F9F44Q38074465-7FDC55D5-AB63-4523-A723-674064CFD665Q38546372-9F0577DE-6911-44B7-9E07-F99BB14F53F6Q39029692-98B6235A-2733-43E8-A5F8-E1964A9FA806Q41868834-039D0D3B-E98F-4EAD-BF3B-7DD20BC3D6B8Q41876578-20C917F1-220D-4A0A-AE80-92145E41FECFQ42035937-356F8F8E-5329-499A-A033-B4CA80C979CFQ43601553-D55FC6C2-0BCF-472E-990D-3BCBBB04DD12Q43948140-49EFFDD7-456E-46F7-B93E-5D777B4A8CB3Q44424889-8751B690-D005-4B1C-8453-0E08D3218CFCQ45886048-F9435020-401E-49E7-8CB1-EA409271D40DQ48308187-15E71418-B873-4607-9554-0B4632915502Q50748144-F286D3E3-E299-437A-8DDC-B06D6244D8B9
P2860
Physical stability of nonviral plasmid-based therapeutics.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Physical stability of nonviral plasmid-based therapeutics.
@ast
Physical stability of nonviral plasmid-based therapeutics.
@en
type
label
Physical stability of nonviral plasmid-based therapeutics.
@ast
Physical stability of nonviral plasmid-based therapeutics.
@en
prefLabel
Physical stability of nonviral plasmid-based therapeutics.
@ast
Physical stability of nonviral plasmid-based therapeutics.
@en
P1476
Physical stability of nonviral plasmid-based therapeutics.
@en
P2093
Anchordoquy TJ
P304
P356
10.1002/(SICI)1520-6017(200003)89:3<289::AID-JPS1>3.0.CO;2-N
P407
P577
2000-03-01T00:00:00Z